Valuation (55%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -3.25 | 2.53 |
PEG Ratio (TTM) | 0.73 | -2.28 |
P/S Ratio (TTM) | 0.18 | 1.16 |
P/B Ratio (TTM) | 2.61 | 1.69 |
P/FCF Ratio (TTM) | 4.30 | 3.56 |
Price to 5YR AVG Earnings Ratio | -0.86 | -10.74 |
Price to 5YR AVG FCF Ratio | 3.13 | 10.39 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -3.38% | -3.95% |
ROE (TTM) | -58.29% | -43.34% |
Net Profit Margin (TTM) | -5.25% | 3.34% |
ROIC 5YR AVG | -21.99% | -1.64% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -29.51% | 7.07% | 31.40% |
Revenue | -0.07% | -11.94% | 1.80% |
Net Income | -29.88% | 3.49% | 27.52% |
Cash Flow | 10.94% | 27.94% | 25.60% |
Health (37%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.88 | 2.02 |
Quick Ratio (TTM) | 1.63 | 1.88 |
D/E Ratio (TTM) | 13.11 | 1.28 |
Interest Coverage (TTM) | 1.22 | 2.69 |
Piotroski F-Score | 6 | 5 |
Altman Z-Score | 0.33 | 1.39 |
LTL to 5YR AVG FCF | 15.19 | -65.12 |
Shares Outstanding Growth 5YR AVG | 6.64% | 3.42% |